Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-22-297725
Filing Date
2022-12-05
Accepted
2022-12-02 21:23:17
Documents
10
Effectiveness Date
2022-12-05

Document Format Files

Seq Description Document Type Size
1 S-3ASR d397733ds3asr.htm S-3ASR 295517
2 EX-1.2 d397733dex12.htm EX-1.2 195461
3 EX-4.2 d397733dex42.htm EX-4.2 375450
4 EX-5.1 d397733dex51.htm EX-5.1 27259
5 EX-5.2 d397733dex52.htm EX-5.2 5431
6 EX-23.1 d397733dex231.htm EX-23.1 2775
7 EX-FILING FEES d397733dexfilingfees.htm EX-FILING FEES 48834
8 GRAPHIC g397733g00a26.jpg GRAPHIC 63475
9 GRAPHIC g397733g1202115233972.jpg GRAPHIC 4262
10 GRAPHIC g397733g1202120634161.jpg GRAPHIC 5864
  Complete submission text file 0001193125-22-297725.txt   1053919
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3ASR | Act: 33 | File No.: 333-268665 | Film No.: 221443615
SIC: 2834 Pharmaceutical Preparations